| 000 | 01833 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518074957.0 | ||
| 264 | 0 | _c20210129 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1879-3177 | ||
| 024 | 7 |
_a10.1016/j.tiv.2019.104754 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Ziheng | |
| 245 | 0 | 0 |
_aCurcumin analog, WZ37, promotes G2/M arrest and apoptosis of HNSCC cells through Akt/mTOR inhibition. _h[electronic resource] |
| 260 |
_bToxicology in vitro : an international journal published in association with BIBRA _cJun 2020 |
||
| 300 |
_a104754 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEndoplasmic Reticulum Stress _xdrug effects |
| 650 | 0 | 4 |
_aG2 Phase Cell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Potential, Mitochondrial _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSquamous Cell Carcinoma of Head and Neck _xdrug therapy |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aLin, Renyu | |
| 700 | 1 | _aLiu, Zhoudi | |
| 700 | 1 | _aYan, Tao | |
| 700 | 1 | _aXia, Yiqun | |
| 700 | 1 | _aZhao, Leping | |
| 700 | 1 | _aLin, Feng | |
| 700 | 1 | _aZhang, Xi | |
| 700 | 1 | _aLi, Chenglong | |
| 700 | 1 | _aWang, Yi | |
| 773 | 0 |
_tToxicology in vitro : an international journal published in association with BIBRA _gvol. 65 _gp. 104754 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tiv.2019.104754 _zAvailable from publisher's website |
| 999 |
_c30446704 _d30446704 |
||